Sanofi India Ltd (BOM:500674)
₹ 6408 60.1 (0.95%) Market Cap: 147.58 Bil Enterprise Value: 145.17 Bil PE Ratio: 32.10 PB Ratio: 21.55 GF Score: 85/100

Q3 2024 Sanofi India Ltd Earnings Call Transcript

Nov 15, 2023 / 08:30AM GMT
Release Date Price: ₹4310.62 (+0.05%)
Operator

Over to the management.

Radhika Shah
Sanofi India Limited - Company Secretary, Compliance Officer & Nodal Officer

Good afternoon, everyone, and a warm welcome to the Investor Call of Sanofi India Limited. My name is Radhika Shah, and I'm the Company Secretary for Sanofi India Limited. I have with me, Mr. Rodolfo Hrosz, Managing Director; Mr. Vaibhav Karandikar, Whole Time Director and CFO; and Mr. Rachid Ayari, Head of Finance.

Rodolfo Hrosz
Sanofi India Limited - MD & Director

All right. Good afternoon, everyone. Very pleased to introduce Mr. Rachid Ayari, currently the Head of Finance. All of you must have read the announcement made post the Board meeting on 8th of November that Rachid has been appointed Chief Financial Officer and Whole Time Director of Sanofi India Limited with effect from December 1, 2023. Vaibhav, at that point, will assume a global role with Sanofi Group, and will accordingly cease to be the CFO and Whole Time Director with effect from the close of the business hour on the 30th of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot